The executive order most directly affecting gender-affirming care is the one that directly attempts to shut down ...
Globally, increases in obesity are projected to continue to 2050 for children and adolescents, and the prevalence of overweight and obesity is set to increase among adults.
After adjustment for confounding variables, researchers found no increased suicide risk for GLP-1 receptor agonists versus DPP-4 inhibitors or SGLT-2 inhibitors.
Mental health comorbidities are more prevalent among transgender and gender nonconforming adults with IBD than the general and IBD US populations.
Factors associated with recurrence of pericarditis include younger age, prednisone treatment, active systemic lupus erythematosus, and time since initial episode.
SGLT2 inhibitors and GLP-1RAs yielded lower risks for COPD exacerbation than DPP-4 inhibitors among patients with type 2 diabetes.
Higher SDI regions had higher burden of osteoarthritis; high body mass index influences osteoarthritis burden, especially in higher SDI countries.
Fragmented sleep is associated with the pathogenesis of metabolic dysfunction-associated steatotic liver disease (MASLD).
Painful diabetic neuropathy was associated with lower quality of life and higher rates of depression and anxiety than painless diabetic neuropathy.
FDA drug alerts in endocrinology, including drug approvals, drug warnings, FDA medical device recalls, and FDA drug label ...
Romosozumab vs bisphosphonate use was not linked to increased CVD risks among patients with osteoporosis, challenging past concerns over its cardiovascular safety.
Patients with RA who have used b/tsDMARDs demonstrated similar risks for multiple myeloma when compared with those taking only csDMARDs.
Results that may be inaccessible to you are currently showing.
Hide inaccessible results